Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Do you prefer stocks holding large amounts of cash? For a closer look high-cash names, we ran a screen.

We began by screening for stocks rallying above their 20-day, 50-day, and 200-day moving averages for those seeing significant net institutional buying over the last quarter, representing at least 5% of share float.

We then screened these names for those with large amounts of cash, with cash holdings/average quarterly operating expense ratios above 4, indicating enough cash to cover average quarterly operating expenses for the next year.

Interactive Chart: Press Play to compare changes in market cap over the last two years for the top six stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Do you think these stocks are in a good position to weather any storm? Use this list as a starting point for your own analysis.

List sorted by net institutional purchases over the last quarter as a percent of share float.

1. Cheniere Energy, Inc. (NYSEMKT:LNG): Engages in the ownership and operation of liquefied natural gas receiving terminals and natural gas pipelines in the Gulf Coast of the United States. Market cap at $1.03B. Price at $17.93. The stock is currently trading 14.21% above its 20-day moving average, 17.31% above its 50-day MA, and 72.43% above its 200-day MA. Average quarterly operating expense over the last five quarters at $66.12M, vs. most recent cash and short term investments at $459.16M, implies a Cash / Avg. Operating Expense ratio at 6.94. Net institutional purchases in the current quarter at 45.4M shares, which represents about 37.58% of the company's float of 120.81M shares.

2. Healthstream Inc. (NASDAQ:HSTM): Provides Internet-based learning and research solutions in the United States. Market cap at $672.62M. Price at $26.14. The stock is currently trading 8.91% above its 20-day moving average, 20.50% above its 50-day MA, and 58.30% above its 200-day MA. Average quarterly operating expense over the last five quarters at $17.35M, vs. most recent cash and short term investments at $83.46M, implies a Cash / Avg. Operating Expense ratio at 4.81. Net institutional purchases in the current quarter at 5.4M shares, which represents about 27.81% of the company's float of 19.42M shares.

3. Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP): Focuses on the discovery, development, and commercialization of drugs based on prostones primarily in the Americas, Europe, and Asia. Market cap at $345.68M. Price at $8.26. The stock is currently trading 4.60% above its 20-day moving average, 11.64% above its 50-day MA, and 71.97% above its 200-day MA. Average quarterly operating expense over the last five quarters at $18.37M, vs. most recent cash and short term investments at $75.11M, implies a Cash / Avg. Operating Expense ratio at 4.09. Net institutional purchases in the current quarter at 1.5M shares, which represents about 11.77% of the company's float of 12.74M shares.

4. American Capital Agency Corp. (NASDAQ:AGNC): Operates as a real estate investment trust. Market cap at $1.98B. Price at $30.71. The stock is currently trading 3.07% above its 20-day moving average, 3.89% above its 50-day MA, and 14.89% above its 200-day MA. Average quarterly operating expense over the last five quarters at $58.98M, vs. most recent cash and short term investments at $1366.89M, implies a Cash / Avg. Operating Expense ratio at 23.17. Net institutional purchases in the current quarter at 26.3M shares, which represents about 11.74% of the company's float of 224.08M shares.

5. Cutera, Inc. (NASDAQ:CUTR): Engages in designing, developing, manufacturing, marketing, and servicing laser and other light-based aesthetics systems for practitioners worldwide. Market cap at $123.60M. Price at $8.94. The stock is currently trading 3.29% above its 20-day moving average, 0.73% above its 50-day MA, and 11.85% above its 200-day MA. Average quarterly operating expense over the last five quarters at $17.5M, vs. most recent cash and short term investments at $88.69M, implies a Cash / Avg. Operating Expense ratio at 5.07. Net institutional purchases in the current quarter at 924.8K shares, which represents about 7.54% of the company's float of 12.26M shares.

6. Onyx Pharmaceuticals Inc. (NASDAQ:ONXX): Engages in developing therapies targeting the molecular mechanisms causing cancer in the United States and internationally. Market cap at $2.63B. Price at $41.60. The stock is currently trading 5.94% above its 20-day moving average, 6.78% above its 50-day MA, and 11.65% above its 200-day MA. Average quarterly operating expense over the last five quarters at $87.14M, vs. most recent cash and short term investments at $646.34M, implies a Cash / Avg. Operating Expense ratio at 7.42. Net institutional purchases in the current quarter at 4.1M shares, which represents about 6.83% of the company's float of 60.04M shares.

7. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR): Provides prescription drugs for central nervous system and inflammatory disorders. Market cap at $2.62B. Price at $41.23. The stock is currently trading 4.60% above its 20-day moving average, 8.80% above its 50-day MA, and 16.64% above its 200-day MA. Average quarterly operating expense over the last five quarters at $24.71M, vs. most recent cash and short term investments at $210.15M, implies a Cash / Avg. Operating Expense ratio at 8.5. Net institutional purchases in the current quarter at 3.4M shares, which represents about 5.69% of the company's float of 59.75M shares.

8. DepoMed Inc. (NASDAQ:DEPO): Develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States. Market cap at $358.13M. Price at $6.36. The stock is currently trading 1.48% above its 20-day moving average, 0.59% above its 50-day MA, and 8.12% above its 200-day MA. Average quarterly operating expense over the last five quarters at $16.38M, vs. most recent cash and short term investments at $86.15M, implies a Cash / Avg. Operating Expense ratio at 5.26. Net institutional purchases in the current quarter at 2.6M shares, which represents about 5.52% of the company's float of 47.13M shares.

9. VIVUS Inc. (NASDAQ:VVUS): Engages in the development and commercialization of therapeutic products for underserved markets in the United States. Market cap at $2.17B. Price at $22.24. The stock is currently trading 2.35% above its 20-day moving average, 14.88% above its 50-day MA, and 89.54% above its 200-day MA. Average quarterly operating expense over the last five quarters at $12.04M, vs. most recent cash and short term investments at $146.84M, implies a Cash / Avg. Operating Expense ratio at 12.2. Net institutional purchases in the current quarter at 3.2M shares, which represents about 5.4% of the company's float of 59.31M shares.

10. POZEN Inc. (NASDAQ:POZN): Develops products for the treatment of acute and chronic pain, and other pain-related conditions in the United States. Market cap at $224.25M. Price at $7.60. The stock is currently trading 18.74% above its 20-day moving average, 44.09% above its 50-day MA, and 95.71% above its 200-day MA. Average quarterly operating expense over the last five quarters at $11.24M, vs. most recent cash and short term investments at $119.62M, implies a Cash / Avg. Operating Expense ratio at 10.64. Net institutional purchases in the current quarter at 1.1M shares, which represents about 5.09% of the company's float of 21.60M shares.

*Institutional data sourced from Fidelity, accounting data sourced from Google Finance, all other data sourced from Finviz.

Source: 10 Rallying High-Cash Stocks Being Bought Up By Hedge Funds